Life course plasma metabolomic signatures of genetic liability to Alzheimer’s disease
Abstract Mechanisms through which most known Alzheimer’s disease (AD) loci operate to increase AD risk remain unclear. Although Apolipoprotein E (APOE) is known to regulate lipid homeostasis, the effects of broader AD genetic liability on non-lipid metabolites remain unknown, and the earliest ages a...
Main Authors: | Hannah Compton, Madeleine L. Smith, Caroline Bull, Roxanna Korologou-Linden, Yoav Ben-Shlomo, Joshua A. Bell, Dylan M. Williams, Emma L. Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-54569-w |
Similar Items
-
Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.
by: Jenna Najar, et al.
Published: (2023-12-01) -
Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization studyResearch in context
by: Madeleine L. Smith, et al.
Published: (2023-04-01) -
Disentangling Independent and Mediated Causal Relationships Between Blood Metabolites, Cognitive Factors, and Alzheimer’s Disease
by: Jodie Lord, et al.
Published: (2022-04-01) -
Genotype-based “virtual” metabolomics in a clinical biobank identifies novel metabolite-disease associations
by: Minoo Bagheri, et al.
Published: (2024-05-01) -
Shared Genetic Liability and Causal Associations Between Major Depressive Disorder and Cardiovascular Diseases
by: Fuquan Zhang, et al.
Published: (2021-11-01)